
Corporate CFOs Think a Recession Is Coming. Here Are 3 Stocks to Own If They're Right.
Many CFOs are decidedly pessimistic these days. The latest CNBC CFO Council Survey found that 60% of CFOs expect a U.S. recession later in 2025. Another 15% predict a recession next year. Ninety percent of the CFOs surveyed believe President Trump's tariffs will cause inflation to rise.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
What should investors do if these CFOs are right? Here are three stocks to own if a recession is coming.
1. Dominion Energy
Utility stocks typically hold up better than most during an economic downturn. Dominion Energy (NYSE: D) ranks as one of the best utility stocks, in my opinion.
Dominion provides electricity to 3.6 million customers in Virginia, North Carolina, and South Carolina, It also provides natural gas to around 500,000 customers in South Carolina. Individuals and businesses will need electricity and natural gas regardless of what's happening with the economy.
The company shouldn't be impacted much by tariffs. If its prices do rise, Dominion Energy would likely be able to pass any increases along to customers, although it would need to secure regulatory approval first.
Unsurprisingly, Dominion Energy's shares are up so far in 2025 while the major market indexes have fallen. This performance reflects the resiliency of the stock. Investors don't have to worry about an absurdly high valuation with Dominion, though: Its forward price-to-earnings ratio is a reasonable 16.5.
What if a recession doesn't materialize? Dominion should still be a good stock to own over the long run. The construction of new data centers should provide a strong tailwind for the company, especially considering Virginia is home to the world's largest data center market.
2. Vertex Pharmaceuticals
A physician looks at the GDP numbers before deciding whether to prescribe a medication that could save the life of a patient with cystic fibrosis (CF). A doctor opts to hold off on giving a patient experiencing acute pain a non-opioid drug that could relieve the pain because the economy is in recession. Do these scenarios seem implausible to you? If so, you might want to own Vertex Pharmaceuticals (NASDAQ: VRTX) if you believe corporate CFOs are right about a recession coming.
Vertex's fortunes were built on the back of its CF franchise. The company markets the only approved therapies that treat the underlying cause of CF. Its newest CF drug, Alyftrek, seems likely to become the most successful CF therapy for Vertex yet.
The company also recently won U.S. regulatory approval for Journavx, a non-opioid drug that's the first new type of pain therapy in more than 20 years. Journavx should have tremendous commercial potential because it's effective at alleviating pain but isn't addictive.
I think the momentum for Alyftrek and Journavx could buoy Vertex if a recession hits. The biotech stock could be an even bigger winner, though, if it reports good news from its late-stage clinical studies. Vertex's pipeline features four phase 3 programs, including a potential cure for severe type 1 diabetes.
3. Walmart
No list of recession-resistant stocks would be complete without mentioning Walmart (NYSE: WMT). The company isn't completely immune to the effects of economic malaise, but is well-positioned to fare better than most.
Walmart, of course, is the world's largest retailer. More importantly (at least if a recession is coming), the company is the largest discount retailer. Customers should continue shopping at Walmart even during a recession because of its "everyday low prices."
Like Dominion Energy (but not Vertex), Walmart pays a quarterly dividend. While the retail giant's dividend yield isn't very high, its dividend track record is impeccable. Walmart is a Dividend King with 52 consecutive years of dividend increases.
The main knock against Walmart is its valuation. Walmart's shares trade at roughly 33.6 times forward earnings. The stock has been even more expensive in the past, though, without hurting its momentum.
Don't miss this second chance at a potentially lucrative opportunity
Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this.
On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves:
Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $286,347!*
Apple: if you invested $1,000 when we doubled down in 2008, you'd have $42,448!*
Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $504,518!*
Right now, we're issuing 'Double Down' alerts for three incredible companies, and there may not be another chance like this anytime soon.
Continue »
*Stock Advisor returns as of April 1, 2025
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
22 minutes ago
- Cision Canada
Aurora Cannabis to Host First Quarter 2026 Investor Conference Call
NASDAQ| TSX: ACB EDMONTON, AB, July 23, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2026 on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2026 before the opening of markets that same day. Conference Call Details Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at under "Events". About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at and follow us on X and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Forward Looking Information This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing for the release of the Company's fiscal 2026 Q1 financial statements and the conference call to discuss the results. These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States; the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 17, 2025 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at and filed with and available on the SEC's website at The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. SOURCE Aurora Cannabis Inc.


Winnipeg Free Press
22 minutes ago
- Winnipeg Free Press
Senator says U.S. tariffs from Trump White House damaging for Washington state
Opponents from Washington state of U.S. President Donald Trump's tariff threats against Canada are vowing to fight, saying the ongoing trade war has delivered a heavy blow to American border communities. In a conference call led by Democrat U.S. Senator Patty Murray that included British Columbia Premier David Eby, Murray said regions such as Whatcom County bordering Canada get about 12 per cent of taxable retail income from Canadian consumers. Murray said the drop in Canadian tourists visiting her state has also resulted in economic uncertainty among ferry operators and in Point Roberts, where residents cannot access the U.S. mainland without travelling through Canada. Eby said it is difficult to continue asking British Columbians to keep their money in Canada but the U.S. boycotts are necessary in the trade war despite circumstances being 'miserable' on both sides of the border. Earlier this week, Eby responded to statements by the U.S. Ambassador to Canada who called Canadians mean and nasty over their travel and alcohol boycott, saying Canadians would be 'proud' to be considered mean for standing up for their sovereignty. Edmund Schweitzer, founder of Washington-based digital device maker Schweitzer Engineering Laboratories, said during the conference call that his company is predicting the tariffs will cost it US$100 million in 'unanticipated federal taxes.' Schweitzer said that means each of the 7,000 employees who co-own the company will take a financial hit of US$14,000 from the tariffs. 'President Trump seems to have created the 51st state that he was talking about, which is the great state of uncertainty,' he said Wednesday. 'And this is affecting all of us.' Murray said she is working in the U.S. Congress to bring Democrats and Republicans to join in the fight to wrestle back the power to set tariffs from the White House and urges other Americans to join the cause. 'Who is responsible for this, and we all need to remember this, is the president of the United States who started this,' Murray said. 'We are raising our voices to say, 'Enough is enough … stop this.' Wednesdays Columnist Jen Zoratti looks at what's next in arts, life and pop culture. B.C. is among several Canadian provinces that banned the sale of U.S. alcohol from government-run stores after the trade war began, and industry groups say such sales in Canada have fallen sharply in March and April. Statistics Canada figures show the number of Canadians returning home by car from south of the border fell to just over 33 per cent in June compared with the same period last year, and return trips by air fell to just over 22 per cent during the same period. 'No one wants this,' Murray said of the falling numbers and economic uncertainty. 'We did not ask for this. It's been imposed on us. And I think that the premier is making it clear he has to make it painful for the United States. 'That doesn't change our relationship with British Columbia. We've always been friends, allies. We have had challenges in the past, but we talk to each other. We work through it, and that's what we both want at the end of this.' This report by The Canadian Press was first published July 23, 2025.


Globe and Mail
22 minutes ago
- Globe and Mail
PFD, PFO, FFC, FLC and DFP Announce Dividends for August, September and October
The Boards of Directors of Flaherty & Crumrine Preferred and Income Fund Incorporated (NYSE: PFD), Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated (NYSE: PFO), Flaherty & Crumrine Preferred and Income Securities Fund Incorporated (NYSE: FFC), Flaherty & Crumrine Total Return Fund Incorporated (NYSE: FLC) and Flaherty & Crumrine Dynamic Preferred and Income Fund Incorporated ( NYSE: DFP) today announced that they have declared per share dividends for August, September and October 2025. These announcements are detailed below: August September October PFD $0.0628 $0.0628 $0.0628 PFO $0.0512 $0.0512 $0.0512 FFC $0.0958 $0.0958 $0.0958 FLC $0.0974 $0.0974 $0.0974 DFP $0.1186 $0.1186 $0.1186 Payment Date August 29, 2025 September 30, 2025 October 31, 2025 Record Date August 22, 2025 September 23, 2025 October 24, 2025 Each fund's fiscal year ends on November 30, 2025. The tax breakdown of all 2025 distributions will be available early in 2026. Website: Past performance is not indicative of future performance. An investor should consider the fund's investment objective, risks, charges and expenses carefully before investing. To the extent any portion of the distribution is estimated to be sourced from something other than income, such as return of capital, the source would be disclosed on a Section 19(a)-1 letter located under the 'SEC Filings and News' section of the funds' website. The actual amounts and sources of the amounts for tax reporting purposes will depend upon a fund's investment performance during the remainder of its fiscal year and may be subject to change based on tax regulations. A distribution rate that is largely comprised of sources other than income may not be reflective of a fund's performance. PFD, PFO and FFC invest primarily in preferred and other income-producing securities with an investment objective of high current income consistent with preservation of capital. FLC invests primarily in preferred and other income-producing securities with a primary investment objective of high current income and a secondary objective of capital appreciation. DFP invests primarily in preferred and other income-producing securities with an investment objective of total return, with an emphasis on high current income. PFD, PFO, FFC, FLC and DFP are managed by Flaherty & Crumrine Incorporated, an independent investment adviser which was founded in 1983 to specialize in the management of portfolios of preferred and related income-producing securities.